ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,814.00
      -0.16%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.60
      -0.88%
      Bitcoin
      62,591.03
      -3.49%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. ImmunoGen Inc (IMGN)

      7. ImmunoGen Inc (IMGN) News

      IMGN

      ImmunoGen (IMGN)

      ImmunoGen Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:IMGN
      DateTimeSourceHeadlineSymbolCompany
      08/01/20234:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
      07/31/20234:15PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IMGNImmunoGen Inc
      07/31/20237:20AMIH Market NewsMonday’s Wall Street Highlights: Palantir Technologies, Walmart, Yellow Corp, J&J, and moreNASDAQ:IMGNImmunoGen Inc
      07/31/20236:40AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IMGNImmunoGen Inc
      07/31/20236:35AMBusiness WireImmunoGen Announces Departure of Anna Berkenblit, Chief Medical OfficerNASDAQ:IMGNImmunoGen Inc
      07/31/20236:30AMBusiness WireImmunoGen Reports Recent Progress and Second Quarter 2023 Financial ResultsNASDAQ:IMGNImmunoGen Inc
      07/27/20234:30PMBusiness WireImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Canaccord Genuity 43rd Annual Growth ConferenceNASDAQ:IMGNImmunoGen Inc
      07/24/20236:30AMBusiness WireImmunoGen Announces Multi-Target License and Option Agreement with ImmunoBiochem to Develop Next-Generation Antibody-Drug ConjugatesNASDAQ:IMGNImmunoGen Inc
      07/17/20234:01PMBusiness WireImmunoGen Announces Conference Call to Discuss Its Second Quarter 2023 Operating ResultsNASDAQ:IMGNImmunoGen Inc
      07/05/20235:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      07/05/20235:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      07/05/20235:56PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      07/05/20235:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      07/05/20235:55PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      07/05/20235:54PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      07/05/20235:53PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      07/05/20235:52PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IMGNImmunoGen Inc
      07/03/20234:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
      06/16/20234:51PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
      06/16/20234:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
      06/16/20234:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
      06/16/20234:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
      06/16/20234:44PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:IMGNImmunoGen Inc
      06/16/20234:17PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:IMGNImmunoGen Inc
      06/09/20233:00AMBusiness WireImmunoGen Presents Updated Findings from CADENZA Trial of Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm at EHA 2023 CongressNASDAQ:IMGNImmunoGen Inc
      06/04/20238:00AMBusiness WireELAHERE® Demonstrates 35% Reduction in the Risk of Disease Progression or Death Versus Chemotherapy in FRα-Positive Platinum-Resistant Ovarian CancerNASDAQ:IMGNImmunoGen Inc
      06/01/20234:30PMBusiness WireImmunoGen Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:IMGNImmunoGen Inc
      05/24/20234:30PMBusiness WireImmunoGen Announces Webcast of Presentation and Q&A at Upcoming Jefferies Healthcare ConferenceNASDAQ:IMGNImmunoGen Inc
      05/09/20234:01PMBusiness WireImmunoGen Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:IMGNImmunoGen Inc
      05/09/20236:30AMBusiness WireImmunoGen Announces Results from the Phase 3 MIRASOL Trial Selected as Late-Breaking Presentation for ASCO 2023 Annual MeetingNASDAQ:IMGNImmunoGen Inc
       Showing the most relevant articles for your search:NASDAQ:IMGN